Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/1999
10/05/1999US5962415 Compositions comprising a peptide inhibitor of nuclear protein translocation and an immunosuppressant and methods of use thereof
10/05/1999US5962414 Modified Bowman-Birk inhibitor
10/05/1999US5962411 Human growth hormone variants and methods of administering same
10/05/1999US5962410 Fungicides, antiprotozoa agent
10/05/1999US5962409 Somatostatin-analogous cyclic peptides with inhibitory activity on growth hormone
10/05/1999US5962406 Recombinant soluble CD40 ligand polypeptide and pharmaceutical composition containing the same
10/05/1999US5962404 Enzymatically-produced oligodendrocyte cytotoxic dimeric IL-2 factor
10/05/1999US5962322 Methods for modulation of cholesterol transport
10/05/1999US5962321 Leukemia inhibitory factor from mammalian species and use thereof to enhance implantation and development of embryos
10/05/1999US5962320 Engineered antigen presenting cells and methods for their use
10/05/1999US5962319 Human-Th1-specific protein, gene encoding the protein, transformants, recombinant vectors, and antibodies related to the gene
10/05/1999US5962316 Cell-cycle regulatory proteins, and uses related thereto
10/05/1999US5962315 DNA encoding p107 tumor suppressor and related polypeptides
10/05/1999US5962314 Certain cells in the body respond not only to chemical signals, but also to ions such as extracellular calcium ions (ca.sup.2+). the invention relates to nucleic acids encoding such receptors and cells containing such nucleic acids.
10/05/1999US5962313 Adeno-associated virus vectors comprising a gene encoding a lyosomal enzyme
10/05/1999US5962311 A method of targeting attachment of a short-shafted recombinant adenovirus to a cell so as to effect entry of the short-shafted recombinant adenovirus into the cell.
10/05/1999US5962303 The invention relates to polynucleotides and polypeptides of bacterial ?topoisomerase iii.?
10/05/1999US5962301 Relatedness of human interleukin-1β convertase gene to a C. elegans cell death gene, inhibitory portions of these genes and uses therefor
10/05/1999US5962298 Influenza vaccine
10/05/1999US5962295 This invention relates to newly identified polynucleotides and polypeptides, and their production and uses, as well as their variants, agonists and antagonists, and their uses.
10/05/1999US5962289 Polysaccharide binding fusion proteins and conjugates
10/05/1999US5962274 Recombinant nucleic acid from simian virus 5 genome; does not express functional membrane bound hemaglutinin neuraminidase protein but fusion of cytoplasmic and membrane domains of protein and exogenous extracellular cell targeting protein
10/05/1999US5962270 Transforming host cell with vector encoding a fusion protein of carbonic anhydrase, linker peptide, and calcitonin; culturing cell to express fusion protein, cleaving protein with hydroxylamine at linker peptide
10/05/1999US5962269 Methods for producing antibodies which specifically bind to interleukin-9 receptor
10/05/1999US5962268 DNA encoding an immune cell cytokine
10/05/1999US5962267 Proinsulin derivative and process for producing human insulin
10/05/1999US5962266 Protease inhibitor peptides
10/05/1999US5962264 Method of reducing the proteolytic degradation of bacillus thuringiensis insecticidal toxic protein
10/05/1999US5962263 Human membrane recycling proteins
10/05/1999US5962262 This invention relates to nucleic acid and amino acid sequences of a new human heat shock 27 like protein and to the use of these sequences in the diagnosis, prevention, and treatment of cancer and immune disorders.
10/05/1999US5962261 Polynucleotides encoding a neuronal extracellular matrix protein
10/05/1999US5962260 Recombinant production of human and bovine receptors for modified low-density lipoprotein
10/05/1999US5962259 Response regulator polynucleotides
10/05/1999US5962257 Flea aminopeptidase nucleic acid molecules
10/05/1999US5962256 Nuclear thyroid hormone receptor-interacting polynucleotides and related molecules and methods
10/05/1999US5962253 Mixing peptide having specific carboxy terminus amino acid sequence and flavoprotein, epid, from epidermin synthesis
10/05/1999US5962252 Assay using marked microbial host cell strains
10/05/1999US5962249 Sized-based marker identification technology
10/05/1999US5962245 Methods for detecting the presence of advanced glycosylation endproducts
10/05/1999US5962243 Assaying for presence of farnesyl protein transferase activity in an enzyme composition by determining transfer of moiety to k-rasb protein or k-rasb peptide having farnesyl acceptor
10/05/1999US5962241 Monoclonal antibody detection of proteins on sperm related to fertility
10/05/1999US5962240 Mycobacterium proteins and applications
10/05/1999US5962236 Immunoassay using antibodies against free lysyl pyridinoline cross-links in unhydrolyzed urine sample
10/05/1999US5962226 Human RNA-binding protein
10/05/1999US5962224 Isolated DNA encoding p62 polypeptides and uses therefor
10/05/1999US5962222 Protein fusions for the translocation of apo-protein into the periplasmic space
10/05/1999US5962220 St receptor binding moieties bind to the st receptor which is found on human colon cells. the invention relates to antisense compositions specifically targeted to colon cells.
10/05/1999US5962219 Systematic evolution of ligands by exponential enrichment: chemi-selex
10/05/1999US5962217 MSRV1 virus and MSRV2 pathogen and/or infective agent associated with multiple sclerosis, and biopolymer constituents thereof
10/05/1999US5962026 Solid compositions of fibrin monomer
10/05/1999US5961984 Human T-cell lymphotropic virus type I envelope protein and human monoclonal antibodies specific therefor
10/05/1999US5961983 Stable pura vectors and uses therefor
10/05/1999US5961979 Complex of a mammalian stress protein noncovalently associated with a peptide that is present in a eukaryotic cell infected with said pathogen but not present in said cell when said cell is not infected with said pathogen
10/05/1999US5961978 Therapeutically useful peptides and peptide fragments
10/05/1999US5961977 Orally administering an autoantigen
10/05/1999US5961976 Monoclonal antibodies characterized by their ability to neutralize in vitro and in vivo primary isolates of human immunodeficiency virus (hiv) and related immunodeficiency viruses.
10/05/1999US5961975 Type I surface antigen associated with staphylococcus epidermidis
10/05/1999US5961974 This invention provides isolated human and murine cd40-l polypeptides that bind to the extracellular binding region of a cd40 receptor. the present invention relates to a novel cytokine.
10/05/1999US5961973 Binding agent which specifically binds a surface component of a pathogen, for instance the gp120 viral coat protein of the human immunodeficiency virus, and a catalytic moiety
10/05/1999US5961971 Biocontrol of fungal soilborne pathogens by Pythium oligandrum
10/05/1999US5961954 Chealators of type XN1 S1 X1 for radioactive isotopes, their metal complexes and their diagnostic and therapeutical uses
10/05/1999CA2161962C Adenovirus vectors for gene therapy
10/05/1999CA2156863C Neuropeptides and their use as insecticides
10/05/1999CA2074182C Process for the reactivation of denatured protein
10/05/1999CA2004646C Protease, reverse transcriptase and endonuclease of retrovirus, and method for producing these enzymes
10/05/1999CA1340779C Plasmids causing densunucleosis; process for preparing the same and their use for the biological control of insect pests
10/05/1999CA1340776C Multispecific antigenic proteins
10/01/1999CA2249043A1 Novel compounds
10/01/1999CA2227508A1 Paip, a novel human protein which bridges the 3' and 5' end of mrna, and use thereof as a target for translational modulation to treat human disease
09/1999
09/30/1999WO1999049316A2 Peripheral-type benzodiazepine receptor: a tool for detection, diagnosis, prognosis, and treatment of cancer
09/30/1999WO1999049293A2 Methods, kits and compositions pertaining to detection complexes
09/30/1999WO1999049064A2 Plant control genes
09/30/1999WO1999049063A1 Protein expression in floral cells
09/30/1999WO1999049061A1 Kinase wee1 fusion protein compositions, nucleotide sequences, expression systems, and methods of use
09/30/1999WO1999049060A1 Use of growth hormone binding protein with a nuclear localization sequence (nls-ghbp)
09/30/1999WO1999049059A2 Methods of cancer diagnosis using a chimeric toxin
09/30/1999WO1999049049A1 Streptococcus sag-a, a structural protein associated with sls activity
09/30/1999WO1999049048A1 Identification genes and gene products involved in cytoadherance of plasmodium infected erythrocytes
09/30/1999WO1999049046A1 Signal transduction protein involved in plant dehiscence
09/30/1999WO1999049045A2 Recombinant major allergen of the pollen of artemisia vulgaris (mugwort)
09/30/1999WO1999049044A1 Cardiostatin polypeptides and polynucleotides
09/30/1999WO1999049043A2 Human rad17 cell cycle checkpoint
09/30/1999WO1999049042A1 HUMAN Rad1 CELL CYCLE CHECKPOINT
09/30/1999WO1999049041A1 Drm, a secreted protein with cell growth inhibiting activity, and related methods and compositions
09/30/1999WO1999049040A1 HUMAN G-PROTEIN COUPLED RECEPTOR GPR6sb
09/30/1999WO1999049039A2 GFRα3 AND ITS USES
09/30/1999WO1999049038A2 Human calcium-binding proteins
09/30/1999WO1999049037A2 Protein phosphatase-related molecules
09/30/1999WO1999049036A1 Lepidopteran gaba gated chloride channel and methods of use thereof
09/30/1999WO1999049035A2 Insecticidal compounds from segestria florentina
09/30/1999WO1999049034A1 Breast cancer antigen
09/30/1999WO1999049033A1 Casb414: antigen overexpressed in several tumors
09/30/1999WO1999049032A1 Suppressors of cytokine signalling
09/30/1999WO1999049030A1 Compounds related to pap-1
09/30/1999WO1999049025A2 Human vault rna
09/30/1999WO1999049023A1 The cytokine family member 2-21
09/30/1999WO1999049019A2 Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics
09/30/1999WO1999049017A2 Mutations responsible for attenuation in measles virus or human respiratory syncytial virus subgroup b
09/30/1999WO1999048927A1 Methods for designing specific ion channel blockers
09/30/1999WO1999048924A1 Endostatin derived peptides with anti-angiogenic and anti-cancer activity